Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug Delivery Devices

PUBLISHER: Grand View Research | PRODUCT CODE: 1751250

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1751250

U.S. Electronic Drug Delivery Devices Market Size, Share & Trends Analysis Report By Product (Smart Infusion Pumps, Smart Transdermal Patches), By Application (Diabetes, Oncology), And Segment Forecasts, 2025 - 2030

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4950
Printable PDF & Excel (5-User License)
USD 5950
Printable PDF & Excel (Enterprise License)
USD 7950

Add to Cart

Description

Table of Contents

List of Tables

U.S. Electronic Drug Delivery Devices Market Growth & Trends:

The U.S. electronic drug delivery devices market size is anticipated to reach USD 37.1 billion by 2030, growing at a CAGR of 7.5% during the forecast period, according to a new report by Grand View Research, Inc. The growing demand for managing chronic conditions like diabetes, cancer-related pain, neuropathic pain, and contraceptive needs has contributed to the rise of the Electronic Drug Delivery Devices (EDDD) industry. These devices provide a controlled method of drug administration that is both more convenient and less painful, while also reducing the risk of side effects. They help ensure that drug levels remain within a specific range, known as the therapeutic window, for optimal effectiveness. The National Cancer Institute forecasts that around 2,001,140 new cancer cases will be diagnosed in the U.S. in 2024. Among these, breast cancer remains the most frequently diagnosed type of cancer in women.

In 2024, an estimated 26.8 million Americans were affected by asthma, including 4.5 million children. This contributes to millions of emergency department visits annually, resulting in tens of billions of dollars in healthcare expenses. In addition, approximately 11.7 million people, or 4.6% of adults, have been diagnosed with chronic obstructive pulmonary disease (COPD).

Patients increasingly prefer managing their health conditions at home, so there is a growing demand for drug delivery devices that enable safe, effective, and easy at-home treatments. Devices such as insulin pumps, auto-injectors, wearable infusion pumps, and pre-filled syringes are becoming indispensable tools in home healthcare because they allow patients to self-administer medications with minimal assistance, offering convenience and autonomy.

U.S. Electronic Drug Delivery Devices Market Highlights

  • Based on product, the Implantable Drug Delivery Devices (IDDD) segment dominated the electronic drug delivery devices industry, accounting for the largest revenue share of 33.0% in 2024.
  • These devices enable daily and monthly drug delivery, reducing the need for frequent dosing and checkups, making them ideal for busy individuals.
  • The Smart Metered Dose Inhalers (SMDIs) segment is expected to grow at the fastest CAGR of 11.0% over the forecast period.
  • Based on application, the diabetes segment led the electronic drug delivery devices industry with the largest revenue share in 2024.
  • The oncology segment is estimated to grow at the largest CAGR over the forecast period.
  • The rising number of cancer cases fuels the growth as these devices offer a superior alternative to traditional injections, revolutionizing drug delivery by effectively improving the bioavailability and enabling precise targeting of therapeutic agents directly to cancerous tissues.
  • In April 2025, Abbott introduced a next-generation delivery system for its Proclaim DRG neurostimulation system. The system is expected to streamline the procedure for implanting a system in patients suffering from CRPS Type 1 and CRPS Type 2 of the lower extremities.
Show more
Product Code: GVR-4-68040-583-3

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Electronic Drug Delivery Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. U.S. Electronic Product Delivery Devices Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Smart Infusion Pumps (Infusion Systems)
    • 4.4.1. Smart Infusion Pumps (Infusion Systems) Market, 2018 - 2030 (USD Million)
    • 4.4.2. Non-Biologic Smart Infusion Systems
      • 4.4.2.1. Non-Biologic Smart Infusion Systems Market, 2018 - 2030 (USD Million)
    • 4.4.3. Biologic Smart Infusion Systems
      • 4.4.3.1. Biologic Smart Infusion Systems Market, 2018 - 2030 (USD Million)
      • 4.4.3.2. Smart Infusion Insulin Pumps
        • 4.4.3.2.1. Smart Infusion Insulin Pumps Market, 2018 - 2030 (USD Million)
      • 4.4.3.3. Other
        • 4.4.3.3.1. Other Market, 2018 - 2030 (USD Million)
  • 4.5. Smart Metered Dose Inhalers (Inhalation Devices)
    • 4.5.1. Smart Metered Dose Inhalers (Inhalation Devices) Market, 2018 - 2030 (USD Million)
  • 4.6. Implantable Drug Delivery Devices
    • 4.6.1. Implantable Drug Delivery Devices Market, 2018 - 2030 (USD Million)
    • 4.6.2. Biologic Implantable Drug Delivery Devices
      • 4.6.2.1. Biologic Implantable Drug Delivery Devices Market, 2018 - 2030 (USD Million)
    • 4.6.3. Non-Biologic Implantable Drug Delivery Devices
      • 4.6.3.1. Non-Biologic Implantable Drug Delivery Devices Market, 2018 - 2030 (USD Million)
  • 4.7. Smart Transdermal Patches (Transdermal Delivery Systems)
    • 4.7.1. Smart Transdermal Patches (Transdermal Delivery Systems) Market, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. U.S. Electronic Drug Delivery Devices Market: Application Business Analysis

  • 5.1. Application Market Share, 2024 & 2030
  • 5.2. Application Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Diabetes
    • 5.4.1. Electronic Drug Delivery Devices Market, for Diabetes, 2018 - 2030 (USD Million)
  • 5.5. Respiratory Devices
    • 5.5.1. Electronic Drug Delivery Devices Market, for Respiratory Devices, 2018 - 2030 (USD Million)
  • 5.6. Oncology
    • 5.6.1. Electronic Drug Delivery Devices Market, for Oncology, 2018 - 2030 (USD Million)
  • 5.7. Cardiology
    • 5.7.1. Electronic Drug Delivery Devices Market, for Cardiology, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Electronic Drug Delivery Devices Market, for Others, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Participant Overview
  • 6.2. Company Market Position Analysis
  • 6.3. Company Categorization
  • 6.4. Strategy Mapping
  • 6.5. Company Profiles/Listing
    • 6.5.1. Medtronic
      • 6.5.1.1. Overview
      • 6.5.1.2. Financial Performance
      • 6.5.1.3. Product Benchmarking
      • 6.5.1.4. Strategic Initiatives
    • 6.5.2. BD
      • 6.5.2.1. Overview
      • 6.5.2.2. Financial Performance
      • 6.5.2.3. Product Benchmarking
      • 6.5.2.4. Strategic Initiatives
    • 6.5.3. Insulet Corporation
      • 6.5.3.1. Overview
      • 6.5.3.2. Financial Performance
      • 6.5.3.3. Product Benchmarking
      • 6.5.3.4. Strategic Initiatives
    • 6.5.4. Tandem Diabetes Care, Inc.
      • 6.5.4.1. Overview
      • 6.5.4.2. Financial Performance
      • 6.5.4.3. Product Benchmarking
      • 6.5.4.4. Strategic Initiatives
    • 6.5.5. Eli Lilly and Company
      • 6.5.5.1. Overview
      • 6.5.5.2. Financial Performance
      • 6.5.5.3. Product Benchmarking
      • 6.5.5.4. Strategic Initiatives
    • 6.5.6. Novo Nordisk A/S
      • 6.5.6.1. Overview
      • 6.5.6.2. Financial Performance
      • 6.5.6.3. Product Benchmarking
      • 6.5.6.4. Strategic Initiatives
    • 6.5.7. Johnson & Johnson Services, Inc.
      • 6.5.7.1. Overview
      • 6.5.7.2. Financial Performance
      • 6.5.7.3. Product Benchmarking
      • 6.5.7.4. Strategic Initiatives
    • 6.5.8. United Therapeutics Corporation
      • 6.5.8.1. Overview
      • 6.5.8.2. Financial Performance
      • 6.5.8.3. Product Benchmarking
      • 6.5.8.4. Strategic Initiatives
    • 6.5.9. Abbott
      • 6.5.9.1. Overview
      • 6.5.9.2. Financial Performance
      • 6.5.9.3. Product Benchmarking
      • 6.5.9.4. Strategic Initiatives
    • 6.5.10. AstraZeneca
      • 6.5.10.1. Overview
      • 6.5.10.2. Financial Performance
      • 6.5.10.3. Product Benchmarking
      • 6.5.10.4. Strategic Initiatives
Show more
Product Code: GVR-4-68040-583-3

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. U.S. electronic drug delivery devices market, by product, 2018 - 2030 (USD Million)
  • Table 4. U.S. electronic drug delivery devices market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 U.S. electronic drug delivery devices market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Product outlook (USD Million)
  • Fig. 9 Application outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 U.S. electronic drug delivery devices market dynamics
  • Fig. 12 U.S. electronic drug delivery devices market: Porter's five forces analysis
  • Fig. 13 U.S. electronic drug delivery devices market: Pestle analysis
  • Fig. 14 U.S. electronic drug delivery devices market: Product segment dashboard
  • Fig. 15 U.S. electronic drug delivery devices market: Product market share analysis, 2024 & 2030
  • Fig. 16 Smart infusion pumps (infusion systems) market, 2018 - 2030 (USD Million)
  • Fig. 17 Non-biologic smart infusion systems market, 2018 - 2030 (USD Million)
  • Fig. 18 Biologic Smart Infusion Systems market, 2018 - 2030 (USD Million)
  • Fig. 19 Smart Infusion Insulin Pumps market, 2018 - 2030 (USD Million)
  • Fig. 20 Others market, 2018 - 2030 (USD Million)
  • Fig. 21 Smart metered dose inhalers (inhalation devices) market, 2018 - 2030 (USD Million)
  • Fig. 22 Implantable Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 23 Biologic implantable drug delivery devices market, 2018 - 2030 (USD Million)
  • Fig. 24 Non-Biologic Implantable Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 25 Smart transdermal patches (transdermal delivery systems) market, 2018 - 2030 (USD Million)
  • Fig. 26 Others market, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. electronic drug delivery devices market: Application segment dashboard
  • Fig. 28 U.S. electronic drug delivery devices market: Application market share analysis, 2024 & 2030
  • Fig. 29 Electronic drug delivery devices market, for diabetes, 2018 - 2030 (USD Million)
  • Fig. 30 Electronic drug delivery devices market, for respiratory devices, 2018 - 2030 (USD Million)
  • Fig. 31 Electronic drug delivery devices market, for oncology, 2018 - 2030 (USD Million)
  • Fig. 32 Electronic drug delivery devices market, for cardiology, 2018 - 2030 (USD Million)
  • Fig. 33 Electronic drug delivery devices market, for others, 2018 - 2030 (USD Million)
  • Fig. 34 Company categorization
  • Fig. 35 Company market position analysis
  • Fig. 36 Strategic framework
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!